Enveric Biosciences, Inc. — Form D

Enveric Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-23. The offering totals $107K, of which $107K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
Sheila W DeWittDirectorCambridge, MA
George W KeglerDirectorCambridge, MA
Frank W PasqualoneDirectorCambridge, MA
Marcus W SchabackerDirectorCambridge, MA
Joseph E TuckerDirectorCambridge, MA
Michael D WebbDirectorCambridge, MA
Kevin M CoveneyExecutive OfficerCambridge, MA
Joseph E TuckerExecutive OfficerCambridge, MA
David JohnsonDirectorGreenwood Village, CO
David JohnsonExecutive OfficerGreenwood Village, CO
David LuciDirectorJersey City, NJ
VIRAJ PATELExecutive OfficerSeattle, WA
Dimitrios AngelisDirectorDenver, CO
Brent KeltonExecutive OfficerAustin, TX
Joseph TuckerDirectorNaples, FL
Joseph TuckerExecutive OfficerNaples, FL
Bob DagherExecutive OfficerNaples, FL
Marcus SchabackerDirectorNaples, FL
Douglas LindDirectorNaples, FL
Frank PasqualoneDirectorCambridge, MA
Frank PasqualoneRelated PersonCambridge, MA
Peter FacchiniExecutive OfficerNaples, FL
George KeglerDirectorNaples, FL
Bevin O'NeilDirectorNaples, FL
Kevin CoveneyExecutive OfficerNaples, FL

Other filings by this issuer (9)

FiledFormOfferingSold
2026-05-04D$5.0M$5.0M
2026-02-11D$1.5M$1.5M
2025-10-03D
2023-04-19D/A$12.8M$12.8M
2022-08-05D$8.6M$8.6M
2021-02-24D$8.4M
2021-01-20D$8.2M
2018-08-28D/A$6.6M$6.6M
2018-08-02D$6.0M$6.0M

More